ChengDa Pharmaceuticals Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 100.89 million compared to CNY 102.2 million a year ago. Revenue was CNY 100.89 million compared to CNY 102.2 million a year ago.

Net income was CNY 18.64 million compared to CNY 19.64 million a year ago. Basic earnings per share from continuing operations was CNY 0.1215 compared to CNY 0.127 a year ago. Diluted earnings per share from continuing operations was CNY 0.1215 compared to CNY 0.127 a year ago.